Related Experiment Video
Updated: Oct 17, 2025
07:53
Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells
Published on: January 18, 2019
8.9K
[Research progress on antibody-dependent enhancement in infectious diseases]
1Department of Central Laboratory, Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 201600, China.
Summary
Antibody-dependent enhancement (ADE) occurs when non-neutralizing antibodies increase viral infection. This review examines ADE in various viruses and discusses its implications for COVID-19 vaccine development and pathogenesis.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Antibody-dependent enhancement (ADE) describes how non-neutralizing antibodies can amplify viral infections.
- This phenomenon involves antibodies binding to viruses and facilitating their entry into cells via Fc receptors.
- ADE poses a significant challenge in developing effective vaccines against various viral diseases.
Purpose of the Study:
- To review the phenomenon of Antibody-dependent enhancement (ADE) in viral infections.
- To explore the potential role of ADE in the high incidence and severity of COVID-19.
- To provide insights into COVID-19 pathogenesis and vaccine development challenges.
Main Methods:
- Literature review of ADE in respiratory syncytial virus, dengue virus, and influenza virus.
- Analysis of potential ADE mechanisms contributing to COVID-19.
- Synthesis of findings to discuss vaccine development and pathogenesis.
Main Results:
- ADE has been observed in infections caused by respiratory syncytial virus, dengue virus, and influenza virus.
- The review explores the potential involvement of ADE in the pathogenesis of COVID-19.
- Understanding ADE is crucial for addressing challenges in vaccine development.
Conclusions:
- Antibody-dependent enhancement (ADE) is a critical consideration for viral vaccine development.
- Further research into ADE mechanisms may elucidate COVID-19 pathogenesis.
- Insights from ADE in other viruses can inform strategies for COVID-19 vaccine design.
More Related Videos
Related Concept Videos
01:41Affinity and Avidity
37.0K
Overview
37.0K
01:26Antibody Actions
1.6K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.6K
01:10Antibody Structure
61.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.8K